Inventor · disambiguated record
John Mckearn
Also filed as: MCKEARN JOHN · MCKEARN JOHN P · MCKEARN JOHN PATRICK
61 granted patents·20 pending applications·1,054 citations·filing 1990–2021
99Inventor score
Top patents by PatentIndex Score
81 records- 0194US6916800B2Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agentPFIZER·Filed 2004·Granted Jul 12, 2005·53 cites·14 claims
- 0293US8258186B2Pharmaceutical for oral delivery comprising MGBGMCKEARN JOHN·Filed 2010·Granted Sep 4, 2012·20 cites·19 claims
- 0391US8609734B2Methods of treating pain with MGBGMCKEARN JOHN·Filed 2012·Granted Dec 17, 2013·14 cites·12 claims
- 0491US6858598B1Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Feb 22, 2005·97 cites·24 claims
- 0591US5858347ATherapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factorsSEARLE & CO·Filed 1995·Granted Jan 12, 1999·83 cites·53 claims
- 0690US10292950B2Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparingPATHOLOGICA LLC·Filed 2017·Granted May 21, 2019·3 cites·18 claims
- 0790US9675566B2Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparingPATHOLOGICA LLC·Filed 2013·Granted Jun 13, 2017·5 cites·8 claims
- 0890US8858991B2Delayed release oral pharmaceutical dosage forms comprising MGBGMCKEARN JOHN·Filed 2012·Granted Oct 14, 2014·11 cites·6 claims
- 0988US6440407B1Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptidesSEARLE & CO·Filed 1996·Granted Aug 27, 2002·37 cites·24 claims
- 1088US5997860AEx-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokinesSEARLE & CO·Filed 1995·Granted Dec 7, 1999·68 cites·44 claims
- 1186US8916560B2Heterocyclic compounds for the inhibition of PASKMCCALL JOHN M·Filed 2012·Granted Dec 23, 2014·6 cites·3 claims
- 1286US6833373B1Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Dec 21, 2004·64 cites·3 claims
- 1385US6730303B1Fused G-CSF and IL-3 proteins and uses thereofPHARMACIA CORP·Filed 2000·Granted May 4, 2004·12 cites·27 claims
- 1484US9868708B2Heterocyclic compounds for the inhibition of PASKBIOENERGENIX LLC·Filed 2015·Granted Jan 16, 2018·3 cites·4 claims
- 1584US9193693B2Heterocyclic compounds for the inhibition of PASKBIOENERGENIX LLC·Filed 2014·Granted Nov 24, 2015·4 cites·11 claims
- 1683US10881626B2Controlled release oral pharmaceutical dosage forms comprising MGBGPATHOLOGICA LLC·Filed 2017·Granted Jan 5, 2021·1 cites·12 claims
- 1783US9668988B2Controlled release oral pharmaceutical dosage forms comprising MGBGPATHOLOGICA LLC·Filed 2014·Granted Jun 6, 2017·4 cites·16 claims
- 1883US6030812AFusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factorsSEARLE & CO·Filed 1995·Granted Feb 29, 2000·47 cites·66 claims
- 1982US10781185B2Heterocyclic compounds for the inhibition of PASKBIOENERGENIX LLC·Filed 2017·Granted Sep 22, 2020·1 cites·3 claims
- 2081US5817486ARecombinant human interleukin-3 (IL-3) multiple mutation polypeptidesSEARLE & CO·Filed 1995·Granted Oct 6, 1998·20 cites·130 claims
- 2181US5772992ACompositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factorsSEARLE & CO·Filed 1994·Granted Jun 30, 1998·36 cites·23 claims
- 2280US5677149AInterleukin-3 (IL-3) mutant polypeptides and their recombinant productionSEARLE & CO·Filed 1993·Granted Oct 14, 1997·27 cites·97 claims
- 2378US6451852B2Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressivesSEARLE & CO·Filed 2001·Granted Sep 17, 2002·7 cites·9 claims
- 2478US6361977B1Methods of using multivariant IL-3 hematopoiesis fusion proteinFiled 1995·Granted Mar 26, 2002·33 cites·62 claims
- 2577US6265439B1Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressivesSEARLE & CO·Filed 2000·Granted Jul 24, 2001·7 cites·22 claims
- 2676US10350178B2Methods and compositions for treatment of demyelinating diseasesPATHOLOGICA LLC·Filed 2018·Granted Jul 16, 2019·1 cites·19 claims
- 2774US6074639AEx vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteinsSEARLE & CO·Filed 1995·Granted Jun 13, 2000·20 cites·60 claims
- 2874US6022535ATreatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factorsSEARLE & CO·Filed 1995·Granted Feb 8, 2000·21 cites·62 claims
- 2974US5604116AInterleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methodsSEARLE & CO·Filed 1993·Granted Feb 18, 1997·20 cites·31 claims
- 3074US5451604AHalogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressivesSEARLE & CO·Filed 1993·Granted Sep 19, 1995·11 cites·4 claims
- 3174US2021085625A1Controlled release oral pharmaceutical dosage forms comprising mgbgPATHOLOGICA LLC·Filed 2020·Application pending·0 cites
- 3273US11459307B2Heterocyclic compounds for the inhibition of PASKBIOENERGENIX LLC·Filed 2020·Granted Oct 4, 2022·0 cites·1 claims
- 3373US9616035B2Pharmaceutical for oral delivery comprising MGBG and methods of treating diseaseMCKEARN JOHN·Filed 2013·Granted Apr 11, 2017·1 cites·7 claims
- 3473US6066318AMulti-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factorsSEARLE & CO·Filed 1997·Granted May 23, 2000·22 cites·58 claims
- 3572US10085955B2Methods and compositions for treatment of demyelinating diseasesPATHOLOGICA LLC·Filed 2014·Granted Oct 2, 2018·1 cites·19 claims
- 3672US6689787B1Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Feb 10, 2004·33 cites·15 claims
- 3772US6057133AMultivariant human IL-3 fusion proteins and their recombinant productionSEARLE & CO·Filed 1994·Granted May 2, 2000·22 cites·70 claims
- 3872US5738849AInterleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising themSEARLE & CO·Filed 1994·Granted Apr 14, 1998·23 cites·44 claims
- 3971US6436387B1Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteinsSEARLE & CO·Filed 1996·Granted Aug 20, 2002·19 cites·48 claims
- 4070US6132991AHuman interleukin-3 (IL-3) variant fusion proteinsSEARLE & CO·Filed 1995·Granted Oct 17, 2000·15 cites·60 claims
- 4170US6100070AG-CSF receptor agonistsSEARLE & CO·Filed 1997·Granted Aug 8, 2000·35 cites·21 claims
- 4269US2005244372A1Interleukin-3 (IL-3) multiple mutation polypeptidesBAUER S C·Filed 2004·Application pending·0 cites
- 4368US5486539AMethod of using phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressivesSEARLE & CO·Filed 1994·Granted Jan 23, 1996·8 cites·3 claims
- 4468US5247119APhenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressivesSEARLE & CO·Filed 1992·Granted Sep 21, 1993·10 cites·10 claims
- 4568US2019224144A1Method of treatment with anti-inflammatory and analgesic compounds which are gi-, renal-, and platelet-sparingPATHOLOGICA LLC·Filed 2019·Application pending·0 cites
- 4665US6051217ATherapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptidesSEARLE & CO·Filed 1995·Granted Apr 18, 2000·15 cites·132 claims
- 4763US2003103936A1Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptidesFiled 2002·Application pending·0 cites
- 4861US6060047ACo-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell productionSEARLE & CO·Filed 1995·Granted May 9, 2000·16 cites·31 claims
- 4961US2004234624A1Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaFiled 2004·Application pending·0 cites
- 5061US2004171115A1Multi-functional hematopoietic fusion proteins between sequence rearranged G-CSF receptor agonists and other hematopoietic factorsFiled 2003·Application pending·0 cites
Showing the top 50 of 81 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →